Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 10;33(1):61-69.
doi: 10.4103/tcmj.tcmj_4_20. eCollection 2021 Jan-Mar.

Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonance imaging functional parameters and 18F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure

Affiliations

Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonance imaging functional parameters and 18F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure

Sheng-Chieh Chan et al. Tzu Chi Med J. .

Abstract

Objectives: The clinical significance of positron emission tomography/magnetic resonance imaging (PET/MRI) functional parameters in nasopharyngealcarcinoma (NPC) remains unclear. The purpose of this prospective study was two-fold: (1) to investigate the associations between simultaneously acquired PET/MRI perfusion, diffusion, and glucose metabolism parameters in patients with NPC and (2) to analyze their predictive value with respect to treatment failure.

Materials and methods: We enrolled 85 patients with primary NPC who simultaneously underwent18F-fluorodeoxyglucose PET/CT and PET/MRI before definitive treatment. The following variables were determined: (1) functional parameters from the MRI component, including perfusion values (Ktrans ,kep ,ve , and initial area under the enhancement curve) and apparent diffusion coefficient (ADC) values, and (2) PET parameters, including metabolic tumor volume (MTV). The reciprocal interrelationships between these parameters and their correlations with treatment failure were examined.

Results: We observed significant negative associations between Ktrans and ADC (r = -0.215, P = 0.049) as well as between ve and ADC (r = -0.22, P = 0.04). Correlations between PET and MRI functional parameters were not statistically significant. Treatment failures were observed in 21.2% of patients without distant metastases. Multivariate analysis identified ve as a significant independent predictor for treatment failure (P = 0.022), whereas MTV showed a borderline significance (P = 0.095). Patients in whom both ve and MTV values were increased had a significantly higher rate of treatment failure (62.5%) than those with either one (21.9%) or no (7.7%) increased parameter (P = 0.004).

Conclusion: Correlation analyses revealed complex interrelationships among PET and MRI indices measured in patients with NPC. These parameters may have a complementary role in predicting treatment failure in this clinical setting.

Keywords: DCE-MRI; Diffusion-weighted MRI; Nasopharyngeal carcinoma; Positron emission tomography/magnetic resonance imaging; Prognosis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Correlations between different PET/MRI functional parameters.Scatter diagrams showing the distribution of PET/MRI Ktrans in relation to kep (panel a), ADC (panel b), and SUVmax (panel c). PET/MRI: Positron emission tomography/magnetic resonance imaging, ADC: Apparent diffusion coefficient, SUVmax: Maximum standardized uptake volume
Figure 2
Figure 2
Boxplots of ve (a) and MTV (b) categorized by treatment failure status. MTV: Metabolic tumor volume
Figure 3
Figure 3
Dot plots of ve against MTV categorized by treatment failure status. The horizontal dashed line on the Y-axis indicates the mean ve value, whereas the vertical dashed line on the X-axis denotes the mean MTV value. Patients with a concomitant increase in both MTV and ve were characterized by a markedly higher rate of failures compared with those with either one or no increased parameter (P = 0.004). MTV: Metabolic tumor volume
Figure 4
Figure 4
A 77-year-old woman with T4N2M0 NPC. T2-weighted (panel a) and contrast-enhanced T1-weighted images (panel b) revealed the presence of a primary nasopharyngeal neoplasm. The corresponding DCE-MRI image with an overlaid ve map (panel c) showed a low value (240.79). According to 18F-FDG PET/MRI (panel d) and PET (panel e) images, the metabolic tumor volume was 8.06. The patient was treated with definitive concurrent chemoradiotherapy. After 2 years of treatment, she is alive without relapses (panel f). The patient had low values of both ve and MTV. NPC: Nasopharyngeal carcinoma, DCE: Dynamic contrast-enhanced, MRI: Magnetic resonance imaging, PET: Positron emission tomography, 18F-FDG: 18F-fluorodeoxyglucose, MTV: Metabolic tumor volume
Figure 5
Figure 5
A 47-year-old male with T4N2M0 NPC. T2-weighted (panel a) and contrast-enhanced T1-weighted images (panel b) revealed the presence of aprimary nasopharyngeal neoplasm. The corresponding DCE-MRI image with an overlaid ve map (panel c) showed a high value (569.02). According to PET (panel e) and PET/MRI (panel d) images, the metabolic tumor volume was 32.31. The patient was treated with definitive concurrent chemoradiotherapy. After 1 year,treatment failures were identified in a neck lymph node (arrow) and at the ribs (arrowhead; panel f). High values of both ve and MTV were noted in this patient. NPC: Nasopharyngeal carcinoma, DCE: Dynamic contrast-enhanced, MRI: Magnetic resonance imaging, PET: Positron emission tomography, MTV: Metabolic tumor volume.

Similar articles

Cited by

References

    1. Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal carcinoma. Lancet. 2016;387:1012–24. - PubMed
    1. O'Sullivan B. Nasopharynx cancer: Therapeutic value of chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2007;69:S118–21. - PubMed
    1. Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: Comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging. 2009;36:12–22. - PubMed
    1. Zheng D, Yue Q, Ren W, Liu M, Zhang X, Lin H, et al. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging. Magn Reson Imaging. 2017;35:125–31. - PubMed
    1. Zhang Y, Liu X, Zhang Y, Li WF, Chen L, Mao YP, et al. Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: A retrospective study of 541 cases. Sci Rep. 2015;5:12242. - PMC - PubMed

LinkOut - more resources